n-methylaspartate has been researched along with Alzheimer Disease in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.80) | 18.7374 |
1990's | 15 (14.02) | 18.2507 |
2000's | 39 (36.45) | 29.6817 |
2010's | 31 (28.97) | 24.3611 |
2020's | 19 (17.76) | 2.80 |
Authors | Studies |
---|---|
Jeong, YI; Kim, D; Kim, T; Park, JS | 1 |
Alberdi, E; Balantzategi, U; Capetillo-Zarate, E; Luchena, C; Matute, C; Ortiz-Sanz, C; Quintela-López, T; Ruiz, A; Zuazo-Ibarra, J; Zugaza, JL | 1 |
Kusiak, A; Ossowska, A; Świetlik, D | 1 |
Lipton, SA | 1 |
Acebes, Á; Acevedo-Arozena, A; Brito-Armas, JM; Cuesto, G; Estévez-Silva, HM; Marcellino, DJ; Romero, N | 1 |
Barger, SW; Wu, S; Zhang, H; Zhou, J | 1 |
Ganeshpurkar, A; Kumar, A; Kumar, D; Sharma, A; Singh, R; Singh, SK; Swetha, R | 1 |
Alvarez-Periel, E; Chowdhury, S; Ghura, S; Jordan-Sciutto, K; Lopez Lloreda, C | 1 |
Baeta-Corral, R; De la Fuente, M; Giménez-Llort, L | 1 |
Cruz-Martins, N; Ezzat, SM; Kumar, D; Li, L; Painuli, S; Semwal, P; Sharifi-Rad, J; Taheri, Y; Zam, W; Zuo, P | 1 |
Aguinaga, D; Franco, R; Navarro, G; Raïch, I; Rivas-Santisteban, R; Saura, CA | 1 |
Chen, YY; Li, HP; Li, Q; Qu, LJ; Xue, Y; Yin, JT; Zhao, XF | 1 |
Chuang, YA; Kirkwood, A; Liu, W; Redding-Ochoa, J; Savonenko, AV; Shi, L; Worley, PF; Wu, J; Yang, L; Zhang, W | 1 |
Emwas, AH; Jaremko, M; Khalilullah, H; Kumar, M; Kumar, P; Narang, R; Singh, V; Sudhakar, K; Thakral, S; Verma, A; Yadav, A | 1 |
Bassi, MS; Buttari, F; Carta, M; Centonze, D; De Rosa, A; Di Maio, A; Errico, F; Gilio, L; Morelli, M; Nuzzo, T; Sasabe, J; Serra, M; Sulzer, D; Usiello, A | 1 |
Becker, S; Cima-Omori, MS; Honigmann, A; Savastano, A; Shen, Z; Sun, D; Varga, SJ; Zweckstetter, M | 1 |
Lewis, SJ; Seckler, JM | 1 |
Chuchmacz, J; Czarnecka, K; Szymański, P; Wójtowicz, P | 1 |
Babaei, P | 1 |
Kuhn, RJ; Sirohi, D | 1 |
Alam, MP; Bai, D; Bilousova, T; Elias, CJ; Evseenko, D; John, V; Spilman, P; Vadivel, K | 1 |
Evans, CE; Freeman, TJ; Good, MA; Hvoslef-Eide, M; Kidd, EJ; Thomas, RS | 1 |
Brummer, T; Endres, K; Fellgiebel, A; Lichtenthaler, SF; Müller, SA; Pan-Montojo, F; Tomita, T; Yoshida, F | 1 |
Arnold, DB; Bayer, KU; Cook, SG; Goodell, DJ; Restrepo, S | 1 |
Angelopoulou, E; Piperi, C | 1 |
Chen, Y; Deng, H; Dong, X; Li, K; Wang, L; Wang, X; Wu, Y; Xu, Y; Zhao, Y | 1 |
Mattson, MP; Wang, Y | 1 |
Chen, P; Chen, S; Deng, Y; Wei, J; Xiong, Z; Yan, Z | 1 |
Huang, YJ; Lane, HY; Lin, CH; Lin, CJ; Tsai, GE | 1 |
Han, SH | 1 |
Han, SH; Mook-Jung, I | 1 |
Borsello, T; Calabresi, P; Costa, C; de Iure, A; Di Filippo, M; Ghiglieri, V; Sclip, A; Tantucci, M; Tozzi, A | 1 |
Cheng, J; Gu, Z; Liu, W; Qin, L; Yan, Z; Zhong, P | 1 |
Arendt, T; Holzer, M; Stieler, J | 1 |
Arias-Carrión, O; Caixeta, L; Campos, C; Machado, S; Nardi, AE; Paes, F; Rocha, NB; Rocha, SA; Telles-Correia, D; Vieira, RT; Yuan, T | 1 |
Glick, JL; McMillan, PA | 1 |
Bermúdez-Rattoni, F; Delint-Ramírez, I; Díaz-Cintra, S; Morin, JP | 1 |
Altomare, CD; Cellamare, S; de Candia, M; Denora, N; Majellaro, M; Tricarico, D; Zaetta, G | 1 |
Amin, ND; Binukumar, BK; Grant, P; Kesavapany, S; Kuntz, S; Mishra, SK; Pant, HC; Reddy, P; Seo, J; Shukla, V; Steiner, J; Tsai, LH | 1 |
Cavaliere, A; Ciavardelli, D; di Ilio, C; Drago, D; Mascetra, N; Sensi, SL; Zatta, P | 1 |
Alpérovitch, A; Dartigues, JF; Lacombe, JM; Pasquier, F; Robert, P; Tzourio, C; Vidal, JS | 1 |
Avila, J; Goñi-Oliver, P; Hernández, F | 1 |
Bakshi, K; Frankfurt, M; Morain, P; Shen, C; Trocmé-Thibierge, C; Wang, HY | 1 |
He, Y; Sheng, W; Simonyi, A; Sun, AY; Sun, GY; Weisman, GA; Wood, WG | 1 |
Goussakov, I; Miller, MB; Stutzmann, GE | 1 |
Cutler, RG; Furukawa, K; Greig, NH; Jiang, H; Lahiri, DK; Lee, JH; Liu, D; Mattson, MP; Mughal, M; Pitta, M; Ray, B; Villarreal, J | 1 |
Becker, KG; Gleichmann, M; Kobilo, T; Markesbery, WR; Mattson, MP; Mughal, MR; Pazin, MJ; Troncoso, JC; van Praag, H; Wood, WH; Zhang, Y; Zonderman, AB | 1 |
Cao, G; Holland, EA; Lipton, SA; McKercher, SR; Nakamura, T; Qu, J | 1 |
Auberson, YP; Bajouco, LM; Ferreira, IL; Mota, SI; Oliveira, CR; Rego, AC | 1 |
Aarsland, D; Ballard, C; Bullock, R; Corbett, A; Francis, PT; Hanney, M; Johnson, T; Jones, EL; Lawrence, D; Prasher, V; Tyrer, S; Williams, N; Yu, LM | 1 |
Hrubá, E; Korábecný, J; Kuca, K; Musílek, K; Nepovímová, E; Opletalová, V; Soukup, O; Spilovská, K; Zemek, F | 1 |
Nakamura, Y | 1 |
Doody, R; Ferris, S; Möbius, HJ; Reisberg, B; Schmitt, F; Stöffler, A | 1 |
Gruol, DL; Qiu, Z | 1 |
Bleich, S; Kornhuber, J; Wiltfang, J | 1 |
Bleich, S; Kornhuber, J; Römer, K; Wiltfang, J | 1 |
Grossman, H; Samuels, SC | 1 |
De Mello, FG; Ferreira, ST; Louzada, PR; Mendonca-Silva, DL; Noël, F; Paula Lima, AC | 1 |
Daniele, A; Di Lazzaro, V; Dileone, M; Gainotti, G; Ghirlanda, S; Marra, C; Oliviero, A; Pilato, F; Saturno, E; Tonali, PA | 1 |
Berezov, T; Boldyrev, A; Carpenter, DO; Koudinov, A | 1 |
Haupt, M; Pirk, O; Stoppe, G | 1 |
Bowen, RL; Gregory, CW | 1 |
Perras, C | 1 |
Humpel, C; Moser, KV | 1 |
Schmitt, HP | 1 |
Almeida, CG; Choi, EY; Gouras, GK; Greengard, P; Lombroso, PJ; Moran, T; Nairn, AC; Nong, Y; Paul, S; Salter, MW; Snyder, EM | 1 |
Souder, E | 1 |
Artioli, P; De Ronchi, D; Quartesan, R; Serretti, A | 1 |
Cheng, XR; Du, GH; Sun, L | 1 |
Smith, DJ | 1 |
Cotter, VT | 1 |
Burnashev, N; Farkas, T; Fülöp, L; Harkany, T; Härtig, W; Holmgren, C; Min, R; Penke, B; Shemer, I; Sousa, KM; Tanila, H; Zilberter, M; Zilberter, Y | 1 |
Gu, Z; Lipton, SA; Ma, Y; Masliah, E; Nakamura, T; Nomura, Y; Shi, ZQ; Uehara, T; Yao, D | 1 |
Christensen, MD; White, HK | 1 |
Felszeghy, K; Horváth, J; Kasza, A; Kurunczi, A; Laroche, S; Párducz, A; Penke, B; Penke, Z; Sipos, E; Toldi, J | 1 |
Downey, D | 1 |
Chalimoniuk, M; Lee, JC; Shelat, PB; Simonyi, A; Strosznajder, JB; Sun, AY; Sun, GY; Wang, JH | 1 |
Choi, DW; Weiss, JH; Yin, HZ | 1 |
Fonnum, F; Myhrer, T; Oksengård, AR; Paulsen, RE; Wangen, K | 1 |
Angeretti, N; Forloni, G; Smiroldo, S | 1 |
Brunner, LC; Cotman, CW; Joyce, JN; Marshall, JF; Ułas, J; Weihmuller, FB | 1 |
Chouinard, ML; Gaitan, D; Wood, PL | 1 |
Kornhuber, J; Weller, M | 1 |
Couratier, P; Esclaire, F; Hugon, J; Lesort, M; Sindou, P; Yardin, C | 1 |
Dalmaz, C; Gutierrez-Figueroa, GP; Izquierdo, I | 1 |
Ceuterick, C; Checler, F; Cordell, B; Cras, P; De Jonghe, C; Dewachter, I; Kumar-Singh, S; Lübke, U; Moechars, D; Naidu, A; Van Broeckhoven, C; Van Leuven, F | 1 |
Beyreuther, K; Emilien, G; Maloteaux, JM; Masters, CL | 1 |
Behrens, MI; Fagan, AM; Han, BH; Holtzman, DM; Lendon, CL; Muller, MC; Salimi, K | 1 |
Brusa, R; Casarini, M; Diodato, E; Grilli, M; Lozza, G; Memo, M; Ongini, E; Rozmahel, R; St George-Hyslop, P; Uberti, D; Westaway, D | 1 |
Jeśko, H; Strosznajder, JB; Strosznajder, RP | 1 |
de Gregorio-Rocasolano, N; Paul, SM; Petegnief, V; Saura, J | 1 |
Hu, GY; Zhang, JM | 1 |
Chen, QS; Shimahara, T; Wei, WZ; Xie, CW | 1 |
Grosche, J; Harkany, T; Härtig, W; Hortobágyi, T; Luiten, PG; Mulder, J; Penke, B; Varga, C | 1 |
Bragin, V; Davis, KL; Haroutunian, V; Merril, CR; Robakis, NK; Sambamurti, K; Santucci, AC; VanderPutten, D; Wallace, WC | 1 |
Klunk, WE; McClure, RJ; Pettegrew, JW | 1 |
Cooper, JD; Sofroniew, MV; Svendsen, CN | 1 |
Fujiwara, M; Fukunaga, R; Kameyama, M; Ninomiya, H; Shimohama, S; Taniguchi, T | 1 |
Chalmers, DT; Dewar, D; Graham, DI; McCulloch, J; Shand, A | 1 |
Baskys, A; Carlen, PL; Reynolds, JN | 1 |
Cotman, CW; Koh, JY; Yang, LL | 1 |
Cotman, CW; Geddes, JW | 1 |
D'Amato, CJ; Greenamyre, JT; Penney, JB; Young, AB | 1 |
Cotman, CW; Monaghan, DT | 1 |
25 review(s) available for n-methylaspartate and Alzheimer Disease
Article | Year |
---|---|
Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathways.
Topics: Alzheimer Disease; Animals; Antioxidants; Biology; Cysteine; Kelch-Like ECH-Associated Protein 1; Mice; N-Methylaspartate; NF-E2-Related Factor 2; Oxidation-Reduction | 2022 |
Serine Racemase Expression Differentiates Aging from Alzheimer's Brain.
Topics: Aging; Alzheimer Disease; Brain; Humans; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Serine | 2022 |
NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer's Disease.
Topics: Alzheimer Disease; Humans; Memantine; N-Methylaspartate; Neurodegenerative Diseases; Receptors, N-Methyl-D-Aspartate | 2023 |
Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.
Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Humans; N-Methylaspartate | 2023 |
Advances in D-Amino Acids in Neurological Research.
Topics: Alzheimer Disease; Amino Acids; Brain; Brain Chemistry; Humans; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2020 |
Memantine in neurological disorders - schizophrenia and depression.
Topics: Alzheimer Disease; Antidepressive Agents; Antipsychotic Agents; Clinical Trials as Topic; Depression; Drug Repositioning; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Memantine; N-Methylaspartate; Neuronal Plasticity; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Serotonin 5-HT3 Receptor Antagonists | 2021 |
NMDA and AMPA receptors dysregulation in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; N-Methylaspartate; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2021 |
Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antigens, Neoplasm; Apoptosis; Blood-Brain Barrier; Brain-Derived Neurotrophic Factor; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Humans; Immunologic Factors; Inflammation; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Models, Biological; N-Methylaspartate; Nerve Tissue Proteins; Neuroimmunomodulation; Neuroprotective Agents; Phosphotransferases (Alcohol Group Acceptor); Rats; Signal Transduction; Species Specificity; Sphingolipids; Sphingosine-1-Phosphate Receptors | 2019 |
NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease.
Topics: Aged; Aging; Alzheimer Disease; Animals; Brain; Cognitive Dysfunction; Disease Models, Animal; Drug Design; Humans; N-Methylaspartate; Neuronal Plasticity; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2014 |
Diverse molecular targets for therapeutic strategies in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antibodies, Monoclonal; Brain; Humans; Immunotherapy; N-Methylaspartate; tau Proteins | 2014 |
Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology.
Topics: Alzheimer Disease; Animals; Brain; Hibernation; Humans; N-Methylaspartate; Neurons; Phosphorylation; Synapses; tau Proteins | 2015 |
Treatment of Cognitive Deficits in Alzheimer's disease: A psychopharmacological review.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Humans; N-Methylaspartate | 2016 |
Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Flavonoids; Humans; Isoenzymes; Molecular Structure; N-Methylaspartate; NADPH Oxidases; Oxidation-Reduction; Oxidative Stress; Phenols; Phospholipases A2; Plant Extracts; Polyphenols; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2010 |
[Intended pharmacotherapeutical approaches of Alzheimer's disease therapy].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Humans; Memantine; N-Methylaspartate | 2012 |
Glutamate and the glutamate receptor system: a target for drug action.
Topics: Alzheimer Disease; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; N-Methylaspartate; Neuroprotective Agents; Receptors, Glutamate; Synaptic Transmission | 2003 |
Emerging therapeutics for Alzheimer's disease: an avenue of hope.
Topics: Alzheimer Disease; Antioxidants; Brain; Cardiovascular Agents; Chelating Agents; Cholinesterase Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Humans; N-Methylaspartate; Nootropic Agents; Vaccines | 2003 |
Novel therapeutic strategies for Alzheimer's disease based on the forgotten reproductive hormones.
Topics: Aging; Alzheimer Disease; Enzyme Inhibitors; Female; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Luteinizing Hormone; Male; N-Methylaspartate | 2005 |
Neuropathology in Alzheimer's disease: target of pharmacotherapy.
Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cholinesterase Inhibitors; Disease Progression; Estrogens; Glutamic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; N-Methylaspartate; Neurofibrillary Tangles; Neuropharmacology; Neurotransmitter Agents | 2005 |
Genes involved in Alzheimer's disease, a survey of possible candidates.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Cathepsin C; Cathepsin G; Cathepsins; DNA, Complementary; Gene Expression; Humans; Membrane Glycoproteins; Membrane Transport Proteins; N-Methylaspartate; Nerve Tissue Proteins; Neurofibrillary Tangles; Plaque, Amyloid; Serine Endopeptidases; Serotonin Plasma Membrane Transport Proteins; Synaptic Transmission; Tryptophan Hydroxylase | 2005 |
[Advances in vulnerable mechanisms of selectively vulnerable neurons].
Topics: Alzheimer Disease; Animals; Brain; Brain Ischemia; Hippocampus; Humans; N-Methylaspartate; Neurons | 2005 |
Alzheimer's disease: issues and challenges in primary care.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Disease Progression; Family; Geriatric Assessment; Geriatric Nursing; Humans; Mass Screening; N-Methylaspartate; Neuropsychological Tests; Nurse's Role; Nursing Assessment; Office Visits; Patient Education as Topic; Primary Health Care; Psychiatric Status Rating Scales; Quality of Life; Self Efficacy; Severity of Illness Index; United States | 2006 |
Dementia assessment and management.
Topics: Activities of Daily Living; Advance Care Planning; Aged; Aged, 80 and over; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Humans; Lewy Body Disease; Long-Term Care; Medical History Taking; Middle Aged; N-Methylaspartate; Neurologic Examination; Nutrition Therapy; Physical Examination; Practice Guidelines as Topic; Safety; Social Support | 2007 |
Pharmacologic management of Alzheimer disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Galantamine; Humans; Indans; Memantine; N-Methylaspartate; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine | 2008 |
[New therapeutic possibilities with low-affinity NMDA receptor antagonists].
Topics: Aged; Alzheimer Disease; Amantadine; Antiparkinson Agents; Excitatory Amino Acid Antagonists; Glutamine; Humans; Memantine; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine | 1996 |
Prospects for pharmacological intervention in Alzheimer disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspartic Acid Endopeptidases; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Endopeptidases; Hippocampus; Humans; Indans; N-Methylaspartate; Nerve Growth Factors; Nicotine; Piperidines; Tacrine | 2000 |
2 trial(s) available for n-methylaspartate and Alzheimer Disease
Article | Year |
---|---|
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Alzheimer Disease; Cognition; Dementia; Double-Blind Method; Down Syndrome; Female; Humans; Male; Memantine; Middle Aged; N-Methylaspartate | 2012 |
Memantine in moderate-to-severe Alzheimer's disease.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Behavior; Cognition; Disease Progression; Excitatory Amino Acid Antagonists; Female; Humans; Male; Memantine; Middle Aged; N-Methylaspartate; Severity of Illness Index | 2003 |
80 other study(ies) available for n-methylaspartate and Alzheimer Disease
Article | Year |
---|---|
The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of
Topics: Alzheimer Disease; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Drug Liberation; Humans; Male; Memantine; Mice; Mice, Inbred BALB C; Mice, Nude; N-Methylaspartate; Nanoparticles; Nerve Tissue Proteins; Neuroblastoma; Optical Imaging; Oxidative Stress; Particle Size; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2021 |
Amyloid β / PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer´s disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Hippocampus; Humans; Integrin beta1; Mice; N-Methylaspartate; Protein Kinase C; Receptors, N-Methyl-D-Aspartate; Synapses | 2022 |
Computational Modeling of Therapy with the NMDA Antagonist in Neurodegenerative Disease: Information Theory in the Mechanism of Action of Memantine.
Topics: Alzheimer Disease; Computer Simulation; Humans; Information Theory; Memantine; N-Methylaspartate; Neurodegenerative Diseases; Receptors, N-Methyl-D-Aspartate | 2022 |
Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer's Disease APP/PS1 Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Hydrogen Peroxide; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; N-Methylaspartate; Neurodegenerative Diseases; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats | 2022 |
Combined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimer's disease.
Topics: Alzheimer Disease; Calcium; Calmodulin; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; N-Methylaspartate; Phosphodiesterase Inhibitors | 2022 |
HIV-Associated Insults Modulate ADAM10 and Its Regulator Sirtuin1 in an NMDA Receptor-Dependent Manner.
Topics: ADAM10 Protein; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; HIV Infections; Humans; Membrane Proteins; N-Methylaspartate; Proteasome Inhibitors; Rats; Receptors, N-Methyl-D-Aspartate; Sirtuin 1 | 2022 |
Sex-dependent worsening of NMDA-induced responses, anxiety, hypercortisolemia, and organometry of early peripheral immunoendocrine impairment in adult 3xTg-AD mice and their long-lasting ontogenic modulation by neonatal handling.
Topics: Alzheimer Disease; Animals; Anxiety; Corticosterone; Disease Models, Animal; Female; Male; Mice; Mice, Transgenic; N-Methylaspartate | 2023 |
The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Humans; Mice; Mice, Transgenic; N-Methylaspartate; Neurons; Phosphorylation; Prion Proteins; Receptors, N-Methyl-D-Aspartate | 2023 |
N-methyl-D-aspartic acid receptor 2A functionalized stationary phase: A reliable method for pursuing potential ligands against Alzheimer's disease from natural products.
Topics: Alzheimer Disease; Biological Products; Humans; Ligands; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate | 2023 |
NMDA Receptor-Arc Signaling Is Required for Memory Updating and Is Disrupted in Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Glycogen Synthase Kinase 3; Hippocampus; Humans; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Knockout; Mice, Transgenic; N-Methylaspartate; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2023 |
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
Topics: Alzheimer Disease; Amino Acids; Amyotrophic Lateral Sclerosis; Homeostasis; Humans; N-Methylaspartate; Parkinson Disease; Putamen; Receptors, N-Methyl-D-Aspartate; Serine | 2023 |
Multivalent Tau/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density.
Topics: Alzheimer Disease; Disks Large Homolog 4 Protein; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; N-Methylaspartate; Nerve Tissue Proteins; Post-Synaptic Density; Receptors, N-Methyl-D-Aspartate | 2023 |
Can an FDA-Approved Alzheimer's Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
Topics: Alzheimer Disease; Cell Death; Humans; N-Methylaspartate; Zika Virus; Zika Virus Infection | 2017 |
A Small Molecule Mimetic of the Humanin Peptide as a Candidate for Modulating NMDA-Induced Neurotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Death; Hippocampus; Intracellular Signaling Peptides and Proteins; N-Methylaspartate; Neurons | 2018 |
Selective reduction of APP-BACE1 activity improves memory via NMDA-NR2B receptor-mediated mechanisms in aged PDAPP mice.
Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Male; Memory; Mice, Transgenic; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate | 2019 |
NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease.
Topics: Acitretin; ADAM10 Protein; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cell Adhesion Molecules; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; N-Methylaspartate; Neuronal Outgrowth; Neurons; Proteolysis; Proteome; Rats; RNA Interference; RNA, Small Interfering; Substrate Specificity; Tetraspanins | 2019 |
Simultaneous Live Imaging of Multiple Endogenous Proteins Reveals a Mechanism for Alzheimer's-Related Plasticity Impairment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disks Large Homolog 4 Protein; Female; Glutamic Acid; Hippocampus; Ionomycin; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Membrane Proteins; N-Methylaspartate; Neuronal Plasticity; Protein Transport; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synapses | 2019 |
Trans-cinnamaldehyde improves neuroinflammation-mediated NMDA receptor dysfunction and memory deficits through blocking NF-κB pathway in presenilin1/2 conditional double knockout mice.
Topics: Acrolein; Alzheimer Disease; Animals; Female; Hippocampus; I-kappa B Proteins; Long-Term Potentiation; Male; Memory Disorders; Mice; Mice, Knockout; Microglia; N-Methylaspartate; Neuroprotective Agents; NF-kappa B; Presenilin-1; Presenilin-2; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2019 |
L-type Ca2+ currents at CA1 synapses, but not CA3 or dentate granule neuron synapses, are increased in 3xTgAD mice in an age-dependent manner.
Topics: Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Amyloid beta-Peptides; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Calcium Channels, L-Type; Cells, Cultured; Cognition Disorders; Dentate Gyrus; Mice; Mice, Inbred C57BL; Mice, Transgenic; N-Methylaspartate; Patch-Clamp Techniques; Phosphorylation; Potassium Channels, Voltage-Gated; Synapses; tau Proteins | 2014 |
β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Glycogen Synthase Kinase 3; Indoles; Male; Maleimides; Mice; Mice, Transgenic; Molecular Targeted Therapy; N-Methylaspartate; Neuronal Plasticity; Neurons; rab5 GTP-Binding Proteins; Rats; Receptors, N-Methyl-D-Aspartate | 2014 |
Increasing burden of Alzheimer's disease by aging.
Topics: Aging; Alzheimer Disease; Cost of Illness; Excitatory Amino Acid Agonists; Health Behavior; Humans; N-Methylaspartate; Risk Factors | 2014 |
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease.
Topics: Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Mice, Transgenic; Molecular Targeted Therapy; Mutation; N-Methylaspartate; Neostigmine; Plaque, Amyloid | 2015 |
Aβ selectively impairs mGluR7 modulation of NMDA signaling in basal forebrain cholinergic neurons: implication in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Choline O-Acetyltransferase; N-Methylaspartate; Nerve Degeneration; Neurons; Parasympathetic Nervous System; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Signal Transduction | 2014 |
A multipronged, nutritional-based strategy for managing Alzheimer's disease.
Topics: Aged; Albumins; Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Animals; Atrophy; Blood-Brain Barrier; Brain; Carbohydrate Metabolism; Diabetes Mellitus; Dietary Supplements; Gray Matter; Homocysteine; Humans; Learning; Magnesium; Magnesium Deficiency; Memory; Middle Aged; Models, Theoretical; N-Methylaspartate; Nutritional Sciences; Plasma Exchange; Rats; Silicic Acid; Vitamin B Complex | 2016 |
Decreased levels of NMDA but not AMPA receptors in the lipid-raft fraction of 3xTg-AD model of Alzheimer's disease: Relation to Arc/Arg3.1 protein expression.
Topics: Alzheimer Disease; Animals; Cytoskeletal Proteins; Disease Models, Animal; Hippocampus; Male; Membrane Microdomains; Mice; Mice, Transgenic; N-Methylaspartate; Nerve Tissue Proteins; Neuronal Plasticity; Neurons; Post-Synaptic Density; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synapses | 2016 |
New azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity.
Topics: Alzheimer Disease; Azepines; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Humans; Indoles; N-Methylaspartate; Neurons; Neuroprotective Agents | 2017 |
TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.
Topics: Alzheimer Disease; Animals; Antipsychotic Agents; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Doxycycline; Excitatory Amino Acid Agonists; Exploratory Behavior; Female; Hippocampus; Hyperkinesis; Long-Term Potentiation; Male; Maze Learning; Mice; Mice, Transgenic; Motor Activity; N-Methylaspartate; Peptides; Phosphotransferases; tau Proteins | 2017 |
Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
Topics: Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium Signaling; Disease Models, Animal; Homeostasis; Humans; In Vitro Techniques; Male; Membrane Fluidity; Mice; Mice, Transgenic; Mitochondria; Multiprotein Complexes; N-Methylaspartate; Neurons; Oxygen Consumption; Peptide Fragments; Rats; Rats, Wistar | 2008 |
Evaluation of the impact of memantine treatment initiation on psychotropics use: a study from the French national health care database.
Topics: Aged; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; Databases, Factual; Dopamine Agents; Female; France; Humans; Hypnotics and Sedatives; Male; Memantine; N-Methylaspartate; Psychotropic Drugs; Treatment Outcome | 2008 |
Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Calpain; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Female; Glycogen Synthase Kinase 3; Humans; Inhibitory Concentration 50; Male; Memantine; Middle Aged; N-Methylaspartate; Neurons; Phosphorylation; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2009 |
S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium; Cholinergic Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Frontal Lobe; Hippocampus; Immunoprecipitation; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Organ Culture Techniques; Peptide Fragments; Phosphorylation; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Synaptosomes | 2010 |
[Alzheimer dementia. Memantine: value for patient and caregivers].
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Caregivers; Cognition; Cost of Illness; Dopamine Agents; Humans; Memantine; N-Methylaspartate | 2009 |
NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cadmium Chloride; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Drug Interactions; Electric Stimulation; Endoplasmic Reticulum; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Heparin; Humans; In Vitro Techniques; Membrane Potentials; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Mutation; N-Methylaspartate; Patch-Clamp Techniques; Prefrontal Cortex; Presenilin-1; Pyramidal Cells; Ryanodine Receptor Calcium Release Channel; tau Proteins; Transglutaminases | 2010 |
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Antipsychotic Agents; Calcium; Cells, Cultured; Cerebral Cortex; Diazoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Gene Expression Regulation; Humans; KATP Channels; Membrane Potential, Mitochondrial; Membrane Potentials; Memory Disorders; Mice; Mice, Transgenic; Mutation; N-Methylaspartate; Oxygen; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Presenilin-1; Rats; RNA, Messenger; tau Proteins; Tauopathies | 2010 |
Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks.
Topics: Aging; Alzheimer Disease; Animals; Calcium Signaling; Cell Survival; Cells, Cultured; Cerebral Cortex; Electroshock; Energy Metabolism; Environment; Gene Expression; Humans; Interneurons; Lipid Metabolism; Mice; Mice, Inbred C57BL; N-Methylaspartate; Nerve Net; Neuronal Plasticity; Receptor, trkB; Synaptic Transmission | 2012 |
[About the NMDA-system again].
Topics: Alcoholism; Alzheimer Disease; Animals; Antipsychotic Agents; Excitatory Amino Acid Agonists; Glutamic Acid; Humans; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synapses | 2011 |
S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Brain; Cyclin-Dependent Kinase 5; Cysteine; Dendritic Spines; Dynamins; Enzyme Activation; HEK293 Cells; Humans; Mutation; N-Methylaspartate; Nitric Oxide; Nitrosation; Rats; Synapses | 2011 |
Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium; Cell Death; Cells, Cultured; Cerebral Cortex; Homeostasis; N-Methylaspartate; Neurons; Peptide Fragments; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2012 |
[New anti-AD drugs--their possibilities and issues].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Galantamine; Humans; Memantine; N-Methylaspartate; Phenylcarbamates; Rivastigmine | 2012 |
Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium Signaling; Cell Death; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Drug Interactions; Encephalitis; Excitatory Amino Acid Agonists; Fetus; Glutamic Acid; Interleukin-6; N-Methylaspartate; Nerve Degeneration; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2003 |
[Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Memantine; N-Methylaspartate | 2003 |
Memantine in moderate-to-severe Alzheimer's disease.
Topics: Alzheimer Disease; Excitatory Amino Acid Antagonists; Homocysteine; Humans; Hyperhomocysteinemia; Memantine; N-Methylaspartate | 2003 |
Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cells, Cultured; Cellular Senescence; Chick Embryo; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Eye Proteins; Glutamic Acid; Kainic Acid; N-Methylaspartate; Neurons; Neuroprotective Agents; Picrotoxin; Receptors, AMPA; Receptors, GABA; Receptors, GABA-A; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Retina; Taurine | 2004 |
Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.
Topics: Afferent Pathways; Aged; Alzheimer Disease; Carbamates; Cerebral Cortex; Cholinergic Fibers; Cholinesterase Inhibitors; Evoked Potentials, Motor; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Motor Cortex; Muscle, Skeletal; N-Methylaspartate; Nerve Net; Neural Inhibition; Phenylcarbamates; Reaction Time; Rivastigmine; Sensory Thresholds; Signal Processing, Computer-Assisted; Transcranial Magnetic Stimulation | 2004 |
Amyloid-beta induced cell death is independent of free radicals.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Animals, Newborn; Calcium; Carnosine; Cell Death; Cell Survival; Cerebellum; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Dyes; Free Radicals; Indicators and Reagents; Intracellular Space; Kainic Acid; N-Methylaspartate; Neurons; Propidium; Rats; Reactive Oxygen Species; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Xanthenes | 2004 |
[Treatment of Alzheimer's disease utilising the best available evidence-based medicine -- utopia?].
Topics: Adult; Alzheimer Disease; Calcium Channel Blockers; Cholinesterase Inhibitors; Drug Costs; Evidence-Based Medicine; Family Practice; Germany; Ginkgo biloba; Humans; Interviews as Topic; Medicine; Middle Aged; N-Methylaspartate; Nootropic Agents; Phytotherapy; Specialization | 2005 |
Memantine for treatment of moderate to severe Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Canada; Cholinesterase Inhibitors; Dementia; Diffusion of Innovation; Dopamine Agents; Drug Approval; Drug Therapy, Combination; Humans; Indans; Memantine; N-Methylaspartate; Nootropic Agents; Randomized Controlled Trials as Topic; Risk Factors | 2005 |
Vascular endothelial growth factor counteracts NMDA-induced cell death of adult cholinergic neurons in rat basal nucleus of Meynert.
Topics: Age Factors; Alzheimer Disease; Animals; Axotomy; Basal Nucleus of Meynert; Blood Vessels; Cell Death; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Excitatory Amino Acid Agonists; Immunohistochemistry; Laminin; Male; N-Methylaspartate; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2005 |
On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease.
Topics: Alzheimer Disease; Brain; Calcium; Calcium Channel Blockers; Clinical Trials as Topic; Humans; Ion Channels; Models, Theoretical; N-Methylaspartate | 2005 |
Regulation of NMDA receptor trafficking by amyloid-beta.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Calcineurin; Cell Membrane; Cerebral Cortex; CREB-Binding Protein; Disease Models, Animal; Electric Conductivity; Endocytosis; Enzyme Activation; Mice; N-Methylaspartate; Neurons; Nuclear Proteins; Peptide Fragments; Protein Transport; Protein Tyrosine Phosphatases; Protein Tyrosine Phosphatases, Non-Receptor; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Signal Transduction; Synapses; Trans-Activators | 2005 |
Basic brain research shows its age.
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Brain; Dentate Gyrus; Gene Expression; Hippocampus; Hormone Replacement Therapy; Humans; Membrane Proteins; N-Methylaspartate; Oligonucleotide Array Sequence Analysis; Presenilin-1 | 2005 |
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
Topics: Action Potentials; Age Factors; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; Disease Models, Animal; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Gene Expression; Immunohistochemistry; Male; Mice; Mice, Transgenic; N-Methylaspartate; Neocortex; Patch-Clamp Techniques; Pyramidal Cells; Receptors, AMPA; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Synapses; Time Factors | 2006 |
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
Topics: Alzheimer Disease; Animals; Binding Sites; Cell Line; Cysteine; Endoplasmic Reticulum; Humans; Molecular Chaperones; N-Methylaspartate; Neurodegenerative Diseases; Nitric Oxide; Parkinson Disease; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Disulfide-Isomerases; Protein Folding; Receptors, G-Protein-Coupled; Sulfhydryl Compounds; Ubiquitin | 2006 |
Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition Disorders; Disease Models, Animal; Entorhinal Cortex; Exploratory Behavior; Gliosis; Male; Maze Learning; Microinjections; N-Methylaspartate; Neurotoxins; Peptide Fragments; Plaque, Amyloid; Rats; Rats, Wistar; Recognition, Psychology; Statistics, Nonparametric | 2007 |
Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Arachidonic Acid; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Extracellular Signal-Regulated MAP Kinases; N-Methylaspartate; NADPH Oxidases; Neurons; Oxidative Stress; Peptide Fragments; Phospholipases A2, Cytosolic; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2008 |
Basal forebrain cholinergic neurons are selectively vulnerable to AMPA/kainate receptor-mediated neurotoxicity.
Topics: Acetylcholine; Acetylcholinesterase; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Animals; Cells, Cultured; Choline O-Acetyltransferase; Kainic Acid; Mice; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Prosencephalon; Receptors, AMPA; Receptors, Kainic Acid | 1994 |
Role of glutamate and glutamate receptors in memory function and Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Animals; Cognition; Cycloserine; Discrimination Learning; Entorhinal Cortex; Female; Glutamic Acid; Humans; Male; Memory; N-Methylaspartate; Rats; Receptors, Glutamate; Temporal Lobe | 1995 |
Neuroprotective activity of acetyl-L-carnitine: studies in vitro.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood Physiological Phenomena; Cattle; Cell Death; Cells, Cultured; Cerebral Cortex; Culture Media; Energy Metabolism; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Hippocampus; Humans; Kainic Acid; N-Methylaspartate; Neurons; Peptide Fragments; Rats | 1994 |
Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amino Acids; Autoradiography; Binding Sites; Carrier Proteins; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Glutamic Acid; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; N-Methylaspartate; Nerve Tissue Proteins; Parkinson Disease; Receptors, Amino Acid; Receptors, AMPA; Receptors, Glutamate | 1994 |
Presence of the N-methyl-D-aspartate-associated glycine receptor agonist, D-serine, in human temporal cortex: comparison of normal, Parkinson, and Alzheimer tissues.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Gas Chromatography-Mass Spectrometry; Humans; Middle Aged; N-Methylaspartate; Parkinson Disease; Rats; Receptors, Glycine; Receptors, Neurotransmitter; Reference Values; Serine; Temporal Lobe | 1993 |
Modifications of neuronal phosphorylated tau immunoreactivity induced by NMDA toxicity.
Topics: Alzheimer Disease; Animals; Brain; Cell Survival; Cells, Cultured; Cerebral Cortex; Fetus; Humans; Kinetics; N-Methylaspartate; Neurons; Neurotoxins; Phosphoproteins; Phosphorylation; Rats; tau Proteins; Time Factors | 1996 |
Effects of entorhinal cortex lesions on memory in different tasks.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Behavior, Animal; Entorhinal Cortex; Excitatory Amino Acid Agents; Male; Maze Learning; Memory Disorders; N-Methylaspartate; Rats; Rats, Wistar; Stereotaxic Techniques | 1997 |
Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.
Topics: Aggression; Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Brain; Cell Nucleus; Cerebral Amyloid Angiopathy; Humans; Kainic Acid; Lethal Dose 50; Mice; Mice, Inbred Strains; Mice, Transgenic; N-Methylaspartate; Point Mutation | 2000 |
No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo.
Topics: Alzheimer Disease; Animals; Animals, Newborn; Antibodies; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Apoptosis; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Gene Expression; Humans; Hypoxia-Ischemia, Brain; In Vitro Techniques; Mice; Mice, Inbred CBA; Mice, Knockout; N-Methylaspartate; Neurons; Neurotoxins; Staurosporine | 2000 |
Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically.
Topics: Alzheimer Disease; Animals; Brain; Cells, Cultured; Disease Models, Animal; Excitatory Amino Acid Agonists; Gene Expression; Humans; Infarction, Middle Cerebral Artery; Kainic Acid; Membrane Proteins; Mice; Mice, Knockout; Mice, Transgenic; N-Methylaspartate; Nerve Degeneration; Neurons; Presenilin-1 | 2000 |
Effect of amyloid beta peptide on poly(ADP-ribose) polymerase activity in adult and aged rat hippocampus.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Cortex; DNA Damage; Free Radicals; Hippocampus; Humans; N-Methylaspartate; Nerve Degeneration; Nitric Oxide; Peptide Fragments; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar | 2000 |
Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E.
Topics: Alzheimer Disease; Animals; Antibodies; Apolipoproteins E; Cell Death; Cell Division; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Glial Fibrillary Acidic Protein; Models, Animal; N-Methylaspartate; Nerve Degeneration; Neuroglia; Neurons; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA, Messenger; Synaptophysin; Time Factors; Up-Regulation | 2001 |
Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons.
Topics: Alkaloids; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Animals; Cells, Cultured; Dithiothreitol; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Glycine; Hippocampus; Hydrogen-Ion Concentration; Kainic Acid; Membrane Potentials; N-Methylaspartate; Neuroprotective Agents; Nootropic Agents; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sesquiterpenes; Spermine; Zinc | 2001 |
Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcineurin; Cyclosporine; Dentate Gyrus; Disease Models, Animal; Hippocampus; Immunosuppressive Agents; Long-Term Potentiation; Male; N-Methylaspartate; Phospholipids; Rats; Rats, Sprague-Dawley; Tacrolimus | 2002 |
Distinct subsets of nucleus basalis neurons exhibit similar sensitivity to excitotoxicity.
Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Basal Nucleus of Meynert; Biomarkers; Carbocyanines; Cell Count; Choline O-Acetyltransferase; Cholinergic Fibers; Down-Regulation; Fluorescent Dyes; Immunoglobulin G; Immunohistochemistry; Male; N-Methylaspartate; Neurons; Neurotoxins; Nuclear Proteins; Rats; Rats, Wistar; Receptor, Nerve Growth Factor | 2002 |
Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Autoradiography; Cerebral Cortex; Choline O-Acetyltransferase; Electrophoresis, Gel, Two-Dimensional; Humans; Male; Methionine; N-Methylaspartate; Polyribosomes; Protein Biosynthesis; Protein Precursors; Rats; Rats, Inbred Strains; Substantia Innominata; Sulfur Radioisotopes | 1991 |
L-phosphoserine, a metabolite elevated in Alzheimer's disease, interacts with specific L-glutamate receptor subtypes.
Topics: 2-Amino-5-phosphonovalerate; Alzheimer Disease; Animals; Dizocilpine Maleate; Dose-Response Relationship, Drug; Glutamates; Glycine; Kainic Acid; N-Methylaspartate; Phosphoserine; Rats; Receptors, Glutamate; Receptors, Neurotransmitter | 1991 |
Trophic factor effects on septal cholinergic neurons.
Topics: Alzheimer Disease; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cholinergic Fibers; Female; Hippocampus; Male; N-Methylaspartate; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Rats; Septal Nuclei | 1991 |
[3H]N-[1-(2-thienyl)cyclohexyl]-3,4-piperidine ([3H]TCP) binding in human frontal cortex: decreases in Alzheimer-type dementia.
Topics: Alzheimer Disease; Aspartic Acid; Binding Sites; Frontal Lobe; Glutamates; Glutamic Acid; Humans; Membranes; N-Methylaspartate; Phencyclidine; Reference Values | 1990 |
Selective reduction of quisqualate (AMPA) receptors in Alzheimer cerebellum.
Topics: Aged; Aged, 80 and over; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Autoradiography; Cerebellum; Female; Glutamates; Glutamic Acid; Humans; Ibotenic Acid; Kainic Acid; Kinetics; Male; N-Methylaspartate; Radioligand Assay; Receptors, AMPA; Receptors, Neurotransmitter | 1990 |
NMDA depolarizations and long-term potentiation are reduced in the aged rat neocortex.
Topics: Aging; Alzheimer Disease; Animals; Cerebral Cortex; Disease Models, Animal; Electric Stimulation; In Vitro Techniques; Membrane Potentials; N-Methylaspartate; Neurons; Rats; Rats, Inbred F344; Time Factors | 1990 |
Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Glutamates; Kainic Acid; L-Lactate Dehydrogenase; Mice; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Neurotoxins | 1990 |
Plasticity in hippocampal excitatory amino acid receptors in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Autoradiography; Female; Glutamates; Glutamic Acid; Hippocampus; Humans; Kainic Acid; Male; Middle Aged; N-Methylaspartate; Neuronal Plasticity; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Synaptic Transmission | 1986 |
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
Topics: Alzheimer Disease; Aspartic Acid; Autoradiography; Flunitrazepam; Glutamates; Glutamic Acid; Hippocampus; Histocytochemistry; Humans; Muscimol; N-Methylaspartate; Receptors, GABA-A; Receptors, Muscarinic; Tissue Distribution | 1987 |
Anatomical organization of excitatory amino acid receptors and their properties.
Topics: Alzheimer Disease; Animals; Aspartic Acid; Autoradiography; Brain; Brain Mapping; Calcium; Glutamates; Humans; N-Methylaspartate; Rats; Receptors, AMPA; Receptors, Drug; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Structure-Activity Relationship | 1986 |